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Medical cannabis is the dried flowers of 
the female Cannabis sativa L. plant. Cannabis 
contains a number of active elements, including 
dronabinol (THC) and cannabidiol (CBD). 
Dronabinol is usually the main ingredient. 
The body’s own cannabinoid system has been 
identified. The discovery of this system, which 
comprises endocannabinoids and receptors, 
confirmed that cannabis has a positive effect 
on certain illnesses and conditions. Two types 
of cannabinoid receptors have been identified: 
CB1 and CB2 receptors. The first type CB1 is 
mostly found in the central nervous system, 
modulate pain. It also has an anti-emetic effect, 
and has influence on the memory and the 
motor system. The second type of receptors 
CB2 is peripheral, and it is primarily found in 
immune system cells and it is responsible for the 
immunomodulatory effects of cannabinoids.
Medical cannabis can help in cases of the 
neurodegeneration disorders, for example 
Parkinson’s disease, Huntington’s Disease, 
Amyotrophic Lateral Sclerosis. Patients 
generally tolerate medical cannabis well.
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